Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Inomata

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Neoplasia (New York, N.Y.)|June 29, 2024
Glycolysis in gastrointestinal stromal tumor: a brief overviewTakafumi Shima, Kohei Taniguchi, Yosuke Inomata, et al.
Plastic and Reconstructive Surgery. Global Open|August 29, 2022
Keloid Nodule Metabolic Activity for Continuous ExpansionKoichi Ueda, Yuumi Lee, Yosuke Inomata, et al.
International Journal of Molecular Sciences|April 30, 2021
Uptake of MicroRNAs from Exosome-Like Nanovesicles of Edible Plant Juice by Rat EnterocytesYuko Ito, Kohei Taniguchi, Yuki Kuranaga, et al.
International Journal of Molecular Sciences|April 27, 2018
Organ-Specific MicroRNAs (<i>MIR122, 137,</i> and <i>206</i>) Contribute to Tissue Characteristics and Carcinogenesis by Regulating Pyruvate Kinase M1/2 (<i>PKM</i>) ExpressionKohei Taniguchi, Nobuhiko Sugito, Haruka Shinohara, et al.
Cancer Science|June 9, 2021
Delta-like canonical Notch ligand 3 as a potential therapeutic target in malignancies: A brief overviewKentaro Matsuo, Kohei Taniguchi, Hiroki Hamamoto, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 25, 2025
Evaluating boron neutron capture therapy as a potential treatment for unresectable gastrointestinal stromal tumorsSeita Hagihara, Jun Arima, Yasuhiko Ueda, et al.
Oncology Reports|November 5, 2021
Glucose transporter‑1 inhibition overcomes imatinib resistance in gastrointestinal stromal tumor cellsTakafumi Shima, Kohei Taniguchi, Yoshihisa Tokumaru, et al.
Molecular Pharmaceutics|October 10, 2019
α-Aminoisobutyric Acid-Containing Amphipathic Helical Peptide-Cyclic RGD Conjugation as a Potential Drug Delivery System for MicroRNA Replacement Therapy in VitroKohei Taniguchi, Shun-Ichi Wada, Yuko Ito, et al.
Molecular Therapy. Nucleic Acids|January 12, 2024
Antitumor effects of chemically modified miR-143 lipoplexes in a mouse model of pelvic colorectal cancer via myristoylated alanine-rich C kinase substrate downregulationJun Arima, Kohei Taniguchi, Nobuhiko Sugito, et al.
International Journal of Molecular Sciences|May 14, 2022
Downregulation of miR-122-5p Activates Glycolysis via PKM2 in Kupffer Cells of Rat and Mouse Models of Non-Alcoholic SteatohepatitisYosuke Inomata, Jae-Won Oh, Kohei Taniguchi, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Neoplasia (New York, N.Y.)|June 29, 2024
Glycolysis in gastrointestinal stromal tumor: a brief overviewTakafumi Shima, Kohei Taniguchi, Yosuke Inomata, et al.
Plastic and Reconstructive Surgery. Global Open|August 29, 2022
Keloid Nodule Metabolic Activity for Continuous ExpansionKoichi Ueda, Yuumi Lee, Yosuke Inomata, et al.
International Journal of Molecular Sciences|April 30, 2021
Uptake of MicroRNAs from Exosome-Like Nanovesicles of Edible Plant Juice by Rat EnterocytesYuko Ito, Kohei Taniguchi, Yuki Kuranaga, et al.
International Journal of Molecular Sciences|April 27, 2018
Organ-Specific MicroRNAs (<i>MIR122, 137,</i> and <i>206</i>) Contribute to Tissue Characteristics and Carcinogenesis by Regulating Pyruvate Kinase M1/2 (<i>PKM</i>) ExpressionKohei Taniguchi, Nobuhiko Sugito, Haruka Shinohara, et al.
Cancer Science|June 9, 2021
Delta-like canonical Notch ligand 3 as a potential therapeutic target in malignancies: A brief overviewKentaro Matsuo, Kohei Taniguchi, Hiroki Hamamoto, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 25, 2025
Evaluating boron neutron capture therapy as a potential treatment for unresectable gastrointestinal stromal tumorsSeita Hagihara, Jun Arima, Yasuhiko Ueda, et al.
Oncology Reports|November 5, 2021
Glucose transporter‑1 inhibition overcomes imatinib resistance in gastrointestinal stromal tumor cellsTakafumi Shima, Kohei Taniguchi, Yoshihisa Tokumaru, et al.
Molecular Pharmaceutics|October 10, 2019
α-Aminoisobutyric Acid-Containing Amphipathic Helical Peptide-Cyclic RGD Conjugation as a Potential Drug Delivery System for MicroRNA Replacement Therapy in VitroKohei Taniguchi, Shun-Ichi Wada, Yuko Ito, et al.
Molecular Therapy. Nucleic Acids|January 12, 2024
Antitumor effects of chemically modified miR-143 lipoplexes in a mouse model of pelvic colorectal cancer via myristoylated alanine-rich C kinase substrate downregulationJun Arima, Kohei Taniguchi, Nobuhiko Sugito, et al.
International Journal of Molecular Sciences|May 14, 2022
Downregulation of miR-122-5p Activates Glycolysis via PKM2 in Kupffer Cells of Rat and Mouse Models of Non-Alcoholic SteatohepatitisYosuke Inomata, Jae-Won Oh, Kohei Taniguchi, et al.
Pageof 2